Home
Commodore Capital reported a 9.9% stake in SAB Biotherapeutics SABS · 4,522,977 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 9.9%
- Last report
- First report
- Shares held
- 4,522,977 sh
- Class
- Common Stock, $0.0001 par value per share
- Holder
- Commodore Capital
- Event date
- 25/09/26
- Filed
- 25/10/03
First 5%+ report · 9.9% stake
SAB Biotherapeutics trades, last 26 weeks
What else happened in SAB Biotherapeutics around then
Filed or reported within 30 days of the trade day · 25/08/27~25/10/26Commodore Capital's other 5% stake reports
- Commodore Capital
5% stakeSurrozen
5% stakeSurrozen
SRZN
7.5% stake
885,000 sh
7.5% stake
Filed 10/01
- Commodore Capital
5% stakeJatt III Acquisition
5% stakeJatt III Acquisition
JTTT
5.2% stake
400,000 sh
5.2% stake
Filed 09/02
- Commodore Capital
5% stakeInflaRx
5% stakeInflaRx
IFRX
5.1% stake
7,475,000 sh
5.1% stake
Filed 08/17
- Commodore Capital
5% stakePalisade Bio
5% stakePalisade Bio
PALI
0% stake
0 sh
0% stake
Filed 08/14
- Commodore Capital
5% stakeJatt II Acquisition
5% stakeJatt II Acquisition
JATT
0% stake
0 sh
0% stake
Filed 08/14
